Literature DB >> 24634372

Circulating tumor cells in patients with testicular germ cell tumors.

Paulina Nastały1, Christian Ruf2, Pascal Becker3, Natalia Bednarz-Knoll1, Małgorzata Stoupiec1, Refik Kavsur1, Hendrik Isbarn4, Cord Matthies3, Walter Wagner3, Dirk Höppner5, Margit Fisch4, Carsten Bokemeyer6, Sascha Ahyai4, Friedemann Honecker6, Sabine Riethdorf1, Klaus Pantel7.   

Abstract

PURPOSE: Germ cell tumors (GCTs) represent the most frequent malignancies among young men, but little is known about circulating tumor cells (CTCs) in these tumors. Considering their heterogeneity, CTCs were investigated using two independent assays targeting germ cell tumor and epithelial cell-specific markers, and results were correlated with disease stage, histology, and serum tumor markers. EXPERIMENTAL
DESIGN: CTCs were enriched from peripheral blood (n = 143 patients) and testicular vein blood (TVB, n = 19 patients) using Ficoll density gradient centrifugation. For CTC detection, a combination of germ cell tumor (anti-SALL4, anti-OCT3/4) and epithelial cell-specific (anti-keratin, anti-EpCAM) antibodies was used. In parallel, 122 corresponding peripheral blood samples were analyzed using the CellSearch system.
RESULTS: In total, CTCs were detected in 25 of 143 (17.5%) peripheral blood samples, whereas only 11.5% of patients were CTC-positive when considering exclusively the CellSearch assay. The presence of CTCs in peripheral blood correlated with clinical stage (P < 0.001) with 41% of CTC positivity in patients with metastasized tumors and 100% in patients with relapsed and chemotherapy-refractory disease. Histologically, CTC-positive patients suffered more frequently from nonseminomatous primary tumors (P < 0.001), with higher percentage of yolk sac (P < 0.001) and teratoma (P = 0.004) components. Furthermore, CTC detection was associated with elevated serum levels of α-fetoprotein (AFP; P = 0.025), β-human chorionic gonadotropin (βHCG; P = 0.002), and lactate dehydrogenase (LDH; P = 0.002). Incidence and numbers of CTCs in TVB were much higher than in peripheral blood.
CONCLUSIONS: The inclusion of germ cell tumor-specific markers improves CTC detection in GCTs. CTCs occur frequently in patients with more aggressive disease, and there is a gradient of CTCs with decreasing numbers from the tumor-draining vein to the periphery. ©2014 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2014        PMID: 24634372     DOI: 10.1158/1078-0432.CCR-13-2819

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  13 in total

Review 1.  SALL4, the missing link between stem cells, development and cancer.

Authors:  Hiro Tatetsu; Nikki R Kong; Gao Chong; Giovanni Amabile; Daniel G Tenen; Li Chai
Journal:  Gene       Date:  2016-02-16       Impact factor: 3.688

Review 2.  Clinical and biological significance of circulating tumor cells in cancer.

Authors:  Takaaki Masuda; Naoki Hayashi; Tomohiro Iguchi; Shuhei Ito; Hidetoshi Eguchi; Koshi Mimori
Journal:  Mol Oncol       Date:  2016-02-10       Impact factor: 6.603

3.  Mediastinal germ cell tumour causing superior vena cava tumour thrombosis.

Authors:  Suman S Karanth; Ashok K Vaid; Sandeep Batra; Devender Sharma
Journal:  BMJ Case Rep       Date:  2015-03-25

4.  Circulating tumor cells: what we know, what do we want to know about them and are they ready to be used in clinics?

Authors:  Zuzana Bielčiková; Anna Jakabová; Michael Pinkas; Milada Zemanová; Katarína Kološtová; Vladimír Bobek
Journal:  Am J Transl Res       Date:  2017-06-15       Impact factor: 4.060

Review 5.  Clinical utility of circulating tumor cells: an update.

Authors:  Antoine Vasseur; Nicolas Kiavue; François-Clément Bidard; Jean-Yves Pierga; Luc Cabel
Journal:  Mol Oncol       Date:  2020-12-25       Impact factor: 6.603

6.  A cell transportation solution that preserves live circulating tumor cells in patient blood samples.

Authors:  Steingrimur Stefansson; Daniel L Adams; William B Ershler; Huyen Le; David H Ho
Journal:  BMC Cancer       Date:  2016-05-06       Impact factor: 4.430

Review 7.  Circulating tumor cells in germ cell tumors: are those biomarkers of real prognostic value? A review.

Authors:  Cristina Ligia Cebotaru; Elena Diana Olteanu; Nicoleta Zenovia Antone; Rares Buiga; Viorica Nagy
Journal:  Clujul Med       Date:  2016-04-15

Review 8.  Circulating Tumor Cells in Genitourinary Malignancies: An Evolving Path to Precision Medicine.

Authors:  Cory M Hugen; Daniel E Zainfeld; Amir Goldkorn
Journal:  Front Oncol       Date:  2017-01-27       Impact factor: 6.244

9.  The biology and clinical potential of circulating tumor cells.

Authors:  Taja Lozar; Klara Gersak; Maja Cemazar; Cvetka Grasic Kuhar; Tanja Jesenko
Journal:  Radiol Oncol       Date:  2019-05-08       Impact factor: 2.991

Review 10.  The Role of Circulating Tumor Cells in the Metastatic Cascade: Biology, Technical Challenges, and Clinical Relevance.

Authors:  Hassan Dianat-Moghadam; Mehdi Azizi; Zahra Eslami-S; Luis Enrique Cortés-Hernández; Maryam Heidarifard; Mohammad Nouri; Catherine Alix-Panabières
Journal:  Cancers (Basel)       Date:  2020-04-03       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.